Renal Cancer - Results from #1860

Tumor-infiltrating CD8+ T cells recognize a heterogeneously expressed functional neoantigen in clear cell renal cell carcinoma. September 9, 2021

Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors. September 8, 2021

Single- versus multi-port robotic partial nephrectomy: a comparative analysis of perioperative outcomes and analgesic requirements. September 8, 2021

P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma. September 7, 2021

Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma. September 7, 2021

Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma. September 6, 2021

Adjuvant therapy in patients with sarcomatoid RCC: Post hoc analysis from ECOG-ACRIN E2805. September 6, 2021

Serum markers change for intraocular metastasis in renal cell carcinoma. September 3, 2021

Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) for Lenvatinib plus Everolimus Versus Everolimus Monotherapy in Patients with Advanced Renal Cell Carcinoma. September 3, 2021

Optimizing the management of patients with small renal masses in a Canadian context: A Markov decision-analysis model. September 2, 2021

Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney Cancer. September 2, 2021

CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma. September 1, 2021

Robotic surgery for cT2 kidney cancer: analysis of the National Cancer Database. August 31, 2021

Molecular underpinnings of glandular tropism in metastatic clear cell renal cell carcinoma: therapeutic implications. August 31, 2021

Systemic Inflammation Response Index is an Independent Prognostic Indicator for Patients with Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional Cohort Study. August 30, 2021

Outcomes in robotic-assisted partial nephrectomy for imperative versus elective indications. August 30, 2021

Aberration of lncRNA LINC00460 is a Promising Prognosis Factor and Associated with Progression of Clear Cell Renal Cell Carcinoma. August 27, 2021

Novel Volumetric and Morphological Parameters Derived from Three-dimensional Virtual Modeling to Improve Comprehension of Tumor's Anatomy in Patients with Renal Cancer. August 27, 2021

Impact of comorbidities on acute kidney injury and renal function impairment after partial and radical tumor nephrectomy. August 26, 2021

[Current treatment options for recurrent/metastatic renal cell carcinoma (mRCC)]. August 26, 2021

Page 94 of 456